Ronald Reagan Institute Casts Doubt on Government Waste Narratives Fueling Fiscal Policy Debate
Micron Briefly Tops 1 Trillion Market Cap as UBS Sees AIDriven Memory Transformation
Health Ministry Reclassifies CNS Drug Pregabalin to Schedule H1 to Curb Misuse
SpaceX Scrubs Starship Test Flight Eyes Friday Launch for Starship V3 Debut
Retirees Face Property Value Risks as Renovation Aversion Depresses Selling Prices
Allstate Corp Faces Analyst Scrutiny What the Latest Report May Reveal
AIOT Q1 2026 Earnings Strong EPS Surprise Drives Stock Gains
OS Q4 2025 Earnings Strong EPS Beat Driven by Operational Efficiency
ARCO Q1 2026 Earnings Profit Surges Past Estimates on Operational Strength Yet Shares Slide
OOMA Q1 2026 Earnings EPS Surpasses Estimates with 786 Beat
Collegium Pharmaceutical Q1 2026 Earnings EPS Surpasses Estimates Amid Strategic Execution
ASRV Q1 2026 Earnings Net Income of 011 per Share as Stock Declines 331
Expand Energy EXE Nears Resistance After Modest Decline
Columbus Acquisition Corp Rights COLAR Surge 1176 Whats Driving the Recent Rally
Tyson Foods TSN Holds Steady Near Support Despite Modest Uptick
BCP Investment Corporation BCIC Holds Steady Near 750 Minor Decline Signals Consolidation
Bluejay Diagnostics BJDX Edges Higher as Shares Hold Above Key Support
Nifty Consolidates Near 23800 Resistance Amid Cautious Market Sentiment
Advantage Solutions Inc ADV Q1 2026 Earnings Staggering EPS Beat Drives Massive Stock Surge
CIMN Bonds Edge Lower as FixedIncome Market Pressures Persist
PrimeEnergy Resources PNRG Q4 2025 Earnings Profitability Holds Firm with EPS of 143 Stock Advances 454
KEQU Q1 2026 Earnings EPS of 028 Reported Stock Edges Lower in Light Trading
PowerFleet Inc AIOT Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Unavailable
BVN Q4 2025 Earnings Stunning EPS Beat Driven by Operational Strength and Higher Metal Prices
DELL Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism
UTMD Q1 2024 Earnings EPS of 109 Highlights Operational Stability Amid Quiet Quarter
BHVN Q1 2026 Earnings EPS Miss Signals Heavy RD Burn as PreRevenue Biotech Navigates Pipeline Progress